Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to examine effects of sleep promotion versus treatment as usual (TAU) on subjective, self-reported sleep while in inpatient psychiatric treatment, to examine effects of sleep promotion vs. TAU/sleep disruption on self-reported depression, anxiety, suicide risk across inpatient length of stay, readmission at 72 hours, objective sleep and to compare implementation outcomes of acceptability and feasibility of sleep promotion relative to TAU/sleep disruption as reported by patients, clinicians, and clinic leaders using mixed methods.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sleep promotion | Experimental | Scented Oil Ear Plugs Eye Mask Video based safety checks will be done as long as participant is asleep. In person safety check will be done once participant is awake |
|
| Treatment as usual | Active Comparator | Only in person safety check will be conducted |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Scented Oil | Drug | inpatient-safe aromatherapy (scented oil) |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Change in nighttime Sleep Quality as assessed by the Pittsburgh Sleep Quality Index (PSQI) | The PSQI has 19 self rated questions with a global score range of 0 to 21.It has 7 components and each is scored from 0 (no difficulty) to 3(severe difficulty) with higher scores indicating poorer sleep quality. | Admission, Discharge (about 2 weeks after admission ) |
| Change in insomnia as assessed by the Insomnia Severity Index (ISI) | The ISI is a 7-item , each item is rated on a 0 (no problem)-4 (very severe problem) scale, with total scores ranging from 0 to 28. Higher scores indicate greater insomnia severity. | Admission, Discharge (about 2 weeks after admission ) |
| Change in daytime Sleepiness as assessed by the Epworth Sleepiness Scale (ESS) | The ESS is an 8-item questionnaire. Each item is scored from 0 (would never doze) to 3 (high chance of dozing). The total score ranges from 0 to 24, with higher scores indicating greater daytime sleepiness. | Admission, Discharge (about 2 weeks after admission ) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in suicide risk as assessed by the Suicide Behaviors Questionnaire Revised (SBQ-R) | The SBQ-R is a 4-item questionnaire, each scored on a different scale. Total scores range from 3 to 18, with higher scores indicating greater suicide risk. Item 1 is scored from 1 [Never (1 point)] to 6 [I have attempted to kill myself more than once (6 points)] Item2 is scored from 1[Never (1 point)] to 5[Very often (5 or more times) (5 points)] Item 3 is scored from 1[No (1 point)] to 5[Yes, more than once, and really wanted to do it (5 points)] Item 3 is scored from 1[Never (1 point)] to 6 [Rather likely (6 points)] |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Michelle Patriquin, PhD, ABPP | Contact | (713) 486-2700 | Michelle.A.Patriquin@uth.tmc.edu | |
| Jessica Badawi | Contact | (713) 486-2700 | Jessica.C.Badawi@uth.tmc.edu |
| Name | Affiliation | Role |
|---|---|---|
| Michelle Patriquin, PhD, ABPP | The University of Texas Health Science Center, Houston | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012893 | Sleep Wake Disorders |
| D059020 | Suicidal Ideation |
| ID | Term |
|---|---|
| D009422 | Nervous System Diseases |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D009812 | Odorants |
| D004430 | Ear Protective Devices |
| ID | Term |
|---|---|
| D004777 | Environment |
| D055669 | Ecological and Environmental Phenomena |
| D001686 | Biological Phenomena |
| D004778 | Environment and Public Health |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Ear Plugs |
| Device |
ingestible-safe ear plugs (noise blocking) |
|
| Eye Mask | Device | inpatient-safe eye mask (light blocking). |
|
| Video based safety check | Behavioral | video based safety checks will be conducted as long as participants are in bed and asleep |
|
| In person safety check | Behavioral | In person safety checks will be conducted every 30 minutes |
|
| Admission, Discharge (about 2 weeks after admission ) |
| Change in Suicide Ideation as assessed by the Beck Scale for Suicide Ideation (BSS) | The Beck Scale for Suicide Ideation (BSS) is a 21-item questionnaire. The first 19 items are scored from 0(No ideation/symptom) to 2 (Severe ideation/symptom) for a maximum score of 38, higher scores indicate greater severity of suicidal ideation. The last 2 items assess past suicide attempts and intent to die during the most recent attempt. These are not included in the total score. | Admission, Discharge (about 2 weeks after admission ) |
| Change in Anxiety as assessed by the Generalized Anxiety Disorder (GAD-7) scale | The GAD-7 is a brief, 7-item questionnaire, and each is scored from 0(not at all) to 3( nearly every day) for a total score range of 0-21, higher score indicating severe anxiety symptoms | Admission, Discharge (about 2 weeks after admission ) |
| Change in Depression as assessed by the Patient Health Questionnaire (PHQ-9) | The PHQ-9 is a 9-item questionnaire, each is scored from 0( not at all) to 3(nearly every day) for a total score range of 0-27, higher scores indicate greater severity of depressive symptoms. | Admission, Discharge (about 2 weeks after admission ) |
| Objective Nighttime Sleep Quantity as assessed by the Total Sleep Time (TST) via ActiGraph wGT3X-BT | Total Sleep Time (TST) is the total amount of actual sleep time recorded during the nighttime sleep period. This measure is objectively assessed using the ActiGraph wGT3X-BT, a validated wrist-worn accelerometer device that estimates sleep parameters based on movement data.TST is calculated as the sum of all sleep epochs during the main sleep period (typically nighttime) and is reported in minutes or hours. | Each night during length of stay (about 2 weeks) |
| Objective Nighttime Sleep Quality as assessed by the Nighttime Awakenings via ActiGraph wGT3X-BT | Nighttime Awakenings refer to the number and/or duration of awakenings during the main sleep period, objectively measured by the ActiGraph wGT3X-BT wrist-worn accelerometer. The device detects movement patterns to identify sleep interruptions, providing an estimate of sleep fragmentation and overall sleep quality. The outcome will be reported as: Total number of awakenings per night | Each night during length of stay(about 2 weeks) |
| D001523 | Mental Disorders |
| D013405 | Suicide |
| D016728 | Self-Injurious Behavior |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D000067393 | Personal Protective Equipment |
| D011482 | Protective Devices |
| D004864 | Equipment and Supplies |
| D011481 | Protective Clothing |
| D003020 | Clothing |
| D008420 | Manufactured Materials |
| D013676 | Technology, Industry, and Agriculture |